GB2353473A - Microemulsion preconcentrates containing a piperidine substance P antagonist - Google Patents

Microemulsion preconcentrates containing a piperidine substance P antagonist

Info

Publication number
GB2353473A
GB2353473A GB0028506A GB0028506A GB2353473A GB 2353473 A GB2353473 A GB 2353473A GB 0028506 A GB0028506 A GB 0028506A GB 0028506 A GB0028506 A GB 0028506A GB 2353473 A GB2353473 A GB 2353473A
Authority
GB
United Kingdom
Prior art keywords
antagonist
piperidine
microemulsion preconcentrates
substance
piperidine substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0028506A
Other languages
English (en)
Other versions
GB0028506D0 (en
Inventor
Steffen Lang
Kurt Liechti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811200.6A external-priority patent/GB9811200D0/en
Priority claimed from GBGB9818105.0A external-priority patent/GB9818105D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of GB0028506D0 publication Critical patent/GB0028506D0/en
Publication of GB2353473A publication Critical patent/GB2353473A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0028506A 1998-05-26 1999-05-26 Microemulsion preconcentrates containing a piperidine substance P antagonist Withdrawn GB2353473A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9811200.6A GB9811200D0 (en) 1998-05-26 1998-05-26 Organic compounds
GBGB9818105.0A GB9818105D0 (en) 1998-08-19 1998-08-19 Organic compounds
PCT/EP1999/003623 WO1999061025A1 (en) 1998-05-26 1999-05-26 Microemulsion preconcentrates containing a piperidine substance p antagonist

Publications (2)

Publication Number Publication Date
GB0028506D0 GB0028506D0 (en) 2001-01-10
GB2353473A true GB2353473A (en) 2001-02-28

Family

ID=26313736

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0028506A Withdrawn GB2353473A (en) 1998-05-26 1999-05-26 Microemulsion preconcentrates containing a piperidine substance P antagonist

Country Status (30)

Country Link
US (2) US20020156099A1 (enExample)
EP (1) EP1082119B1 (enExample)
JP (1) JP4083985B2 (enExample)
KR (1) KR20010043669A (enExample)
CN (1) CN1270714C (enExample)
AR (1) AR018376A1 (enExample)
AT (1) ATE257380T1 (enExample)
AU (1) AU755134B2 (enExample)
BE (1) BE1012143A5 (enExample)
BR (1) BR9910696A (enExample)
CA (1) CA2333154C (enExample)
DE (2) DE19983247T1 (enExample)
DK (1) DK1082119T3 (enExample)
ES (1) ES2214859T3 (enExample)
FR (1) FR2779145B1 (enExample)
GB (1) GB2353473A (enExample)
HU (1) HUP0102202A3 (enExample)
ID (1) ID27096A (enExample)
IL (1) IL139501A0 (enExample)
IT (1) IT1313551B1 (enExample)
NO (1) NO20005920L (enExample)
NZ (1) NZ508325A (enExample)
PE (1) PE20000537A1 (enExample)
PL (1) PL344245A1 (enExample)
PT (1) PT1082119E (enExample)
RU (1) RU2240121C2 (enExample)
SK (1) SK17752000A3 (enExample)
TR (1) TR200003502T2 (enExample)
TW (1) TW537894B (enExample)
WO (1) WO1999061025A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
AU2003225260A1 (en) * 2002-04-22 2003-11-03 University Of Florida Microemulsions for selective molecular separation
GB0220953D0 (en) 2002-09-10 2002-10-23 Novartis Ag Organic compounds
US7842791B2 (en) 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
FR2935001B1 (fr) * 2008-08-14 2011-12-30 Commissariat Energie Atomique Emulsion fluorescente
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
EP2938324B1 (en) 2012-12-31 2023-11-08 JRX Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2278780A (en) * 1993-05-27 1994-12-14 Sandoz Ltd Macrolide antibiotic emulsions
EP0707006A1 (de) * 1994-10-14 1996-04-17 Ciba-Geigy Ag Aroyl-piperidin-Derivate
EP0722722A1 (fr) * 1994-12-19 1996-07-24 L'oreal Utilisation d'un antagoniste de substance P pour le traitement des rougeurs cutanées d'origine neurogène
EP0826684A1 (en) * 1995-03-27 1998-03-04 Hisamitsu Pharmaceutical Co., Inc. Piperidine derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305689A1 (de) 1983-02-18 1984-08-23 Mack Chem Pharm Pharmazeutische zubereitung mit retardwirkung
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
DE4220616C2 (de) 1992-06-24 1994-12-22 Byk Gulden Lomberg Chem Fab Dexniguldipin zur intravenösen Verabreichung
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
GB2308545B (en) 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
FR2728169A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
WO1997045119A1 (en) 1996-05-24 1997-12-04 Novartis Ag Use of substance p antagonists for treating social phobia
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2278780A (en) * 1993-05-27 1994-12-14 Sandoz Ltd Macrolide antibiotic emulsions
EP0707006A1 (de) * 1994-10-14 1996-04-17 Ciba-Geigy Ag Aroyl-piperidin-Derivate
EP0722722A1 (fr) * 1994-12-19 1996-07-24 L'oreal Utilisation d'un antagoniste de substance P pour le traitement des rougeurs cutanées d'origine neurogène
EP0826684A1 (en) * 1995-03-27 1998-03-04 Hisamitsu Pharmaceutical Co., Inc. Piperidine derivatives

Also Published As

Publication number Publication date
IT1313551B1 (it) 2002-09-09
HK1035137A1 (en) 2001-11-16
CA2333154C (en) 2008-07-08
DE69914077D1 (de) 2004-02-12
EP1082119A1 (en) 2001-03-14
EP1082119B1 (en) 2004-01-07
PT1082119E (pt) 2004-05-31
TR200003502T2 (tr) 2001-04-20
DE69914077T2 (de) 2004-06-09
CN1270714C (zh) 2006-08-23
FR2779145A1 (fr) 1999-12-03
GB0028506D0 (en) 2001-01-10
JP2002516280A (ja) 2002-06-04
CA2333154A1 (en) 1999-12-02
ES2214859T3 (es) 2004-09-16
NZ508325A (en) 2003-06-30
NO20005920D0 (no) 2000-11-23
HUP0102202A2 (hu) 2001-11-28
AU4500899A (en) 1999-12-13
TW537894B (en) 2003-06-21
BR9910696A (pt) 2001-01-30
US20020156099A1 (en) 2002-10-24
AU755134B2 (en) 2002-12-05
SK17752000A3 (sk) 2001-05-10
JP4083985B2 (ja) 2008-04-30
DE19983247T1 (de) 2001-05-31
RU2240121C2 (ru) 2004-11-20
ITMI991164A1 (it) 2000-11-26
DK1082119T3 (da) 2004-04-13
IL139501A0 (en) 2001-11-25
KR20010043669A (ko) 2001-05-25
WO1999061025A1 (en) 1999-12-02
ATE257380T1 (de) 2004-01-15
US20030152626A1 (en) 2003-08-14
BE1012143A5 (fr) 2000-05-02
NO20005920L (no) 2001-01-25
PE20000537A1 (es) 2000-07-10
AR018376A1 (es) 2001-11-14
HUP0102202A3 (en) 2003-01-28
US6949257B2 (en) 2005-09-27
PL344245A1 (en) 2001-10-08
FR2779145B1 (fr) 2004-07-30
CN1303285A (zh) 2001-07-11
ID27096A (id) 2001-03-01

Similar Documents

Publication Publication Date Title
PT1446387E (pt) Derivados de aril-1,4-pirazina substituídos
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
WO2000043032A3 (en) Baff, inhibitors thereof and their use in the modulation of b-cell response
FR16C0038I1 (enExample)
ATE285809T1 (de) Vorrichtung zur verabreichung einer substanz
PL371736A1 (en) Method for administering glp-1 molecules
GB2365772A (en) Factor
PT1465693E (pt) Sistema descartável gerador de aerossol e métodos para administrar o aerossol
ZA200006312B (en) Antibodies to CD23, derivatives thereof, and their therapeutic uses.
ZA200005154B (en) Pulmonary and nasal delivery of raloxifene.
PL361833A1 (en) Modified inorganic particles, method of their manufakturing and use thereof
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
WO2002102586A3 (en) Cellulose-polymer composites and methods for manufacturing same
GB2353473A (en) Microemulsion preconcentrates containing a piperidine substance P antagonist
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
MY122838A (en) Treating allergic and inflammatory conditions
EP1558282A4 (en) COMPOSITIONS AGAINST CANCER AND INFECTION DISEASES AND METHOD OF USE THEREOF
AU3598299A (en) Improved compositions for inhalation
NZ335052A (en) Piperazino derivatives as neurokinin antagonists
EP1303520A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
MY127675A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
AU5100201A (en) Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods ofuse thereof
ZA954947B (en) Novel substituted alkyldiamine derivatives

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)